Author:
Cheng Ying,Liu Miao,Hu Huijing,Liu Daozhou,Zhou Siyuan
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference50 articles.
1. Makino H, Aoki M, Hashiya N, Yamasaki K, Hiraoka K, Shimizu H, et al. Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor. Hypertens Res. 2004;27(2):85–91.
2. Acciavatti A, Laghi Pasini F, Capecchi PL, Messa GL, Lazzerini PE, De Giorgi L, et al. Effects of alprostadil on blood rheology and nucleoside metabolism in patients affected with lower limb chronic ischaemia. Clin Hemorheol Microcirc. 2001;24(1):49–57.
3. Bandinelli F, Bartoli F, Perfetto E, Del Rosso A, Moggi-Pignone A, Guiducci S, et al. The fibrinolytic system components are increased in systemic sclerosis and modulated by alprostadil (alpha1 ciclodestryn). Clin Exp Rheumatol. 2005;23(5):671–7.
4. Marquis NR, Vigdahl RL, Tavormina PA. Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochem Biophys Res Commun. 1969;36(6):965–72.
5. Hirai M, Nakayama R. Haemodynamic effects of intra-arterial and intravenous administration of prostaglandin E1 in patients with peripheral arterial disease. Br J Surg. 1986;73(1):20–3.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献